Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $20.75 and last traded at $20.55, with a volume of 845796 shares traded. The stock had previously closed at $19.24. Analysts Set New Price Targets Several equities research analysts […]
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year […]
NeoGenomics (NASDAQ:NEO – Get Free Report) updated its FY 2023 earnings guidance on Monday. The company provided earnings per share guidance of -$0.18–$0.15 for the period, compared to the consensus earnings per share estimate of -$0.28. The company issued revenue guidance of $585.00 million-$592.00 million, compared to the consensus revenue estimate of $573.19 million. Analyst […]
Analysts Set NeoGenomics, Inc. (NASDAQ:NEO) Price Target at $18.42 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
NeoGenomics (NASDAQ:NEO – Free Report) had its price target lowered by Piper Sandler from $23.00 to $18.00 in a report released on Monday, Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. A number of other brokerages also recently issued reports on NEO. Morgan Stanley cut their price objective […]